Kikuo Iwata, a nominee for deputy governorship at the central bank said that the BOJ must work to achieve its 2% inflation target within two years at the latest, a day after Haruhiko Kuroda, the nominee for governor, outlined a forceful policy to defeat deflation.
The Nikkei advanced 0.3% to 11,683.45, its highest close since September 2008. At one point, it rose as high as 11,779.42, also its highest level since September 2008.
"(Kuroda) is the absolutely perfect guy in there and probably the best one for the stock market," said Nicholas Smith, Japan strategist at CLSA.
"This is absolutely not a yen story. This is about an asset price reflation story, so don't concentrate your forces in exporters, concentrate on ... banks, brokers and real estate," Smith said.
The market was quick to price in the confirmation hearings, and investors took profits on recently gained exporters, financials and real estates.
"The market is already convinced that there will be easing. But it won't happen until April at earliest, so it's not something new," said Fujio Ando, senior managing director at Chibagin Securities.
Index heavyweight Fast Retailing Co, however, jumped 5.5% after its Uniqlo casual-clothing chain posted a 9.6% year-on-year increase in same-store sales in Japan last month.
Sony Corp dropped 0.9%, Mitsubishi UFJ Financial Group fell 0.8% and Sumitomo Mitsui Financial Group declined 0.5%.
The banking sector has rallied about 50% since mid-November after Prime Minister Shinzo Abe called on the BOJ to embark on bold monetary policy to whip deflation, outpacing a 35% rise in the benchmark Nikkei during the same period.
Real estate stocks were weaker, with Mitsui Fudosan Co shedding 2.1% and Mitsubishi Estate Co also dropping 2.1%, dragging down the broader Topix, which fell 0.4% to 988.62.
Volume was moderate, with 3.08 billion shares changing hands. It compares to last week's average daily volume of 3.32 billion shares.
CONCERN
Hisamitsu Pharmaceutical Co Inc sank 5.2% after a panel of advisers to the US Food and Drug Administration recommended that the agency reject a drug for hot flashes associated with menopause made by Hisamitsu's subsidiary Noven Pharmaceutical Inc.
Some market players are worried that the latest strength in Tokyo shares may not be justified given an uncertain global economic outlook as the US economy faces automatic spending cuts and Europe struggles with Italian political crisis.
"I think it's becoming a bit like an asset bubble. Retail investors are looking to buy laggards everyday. Their moves determine the direction of the stock market in the short term. They don't care about fundamentals," said Yasuo Sakuma, portfolio manager at Bayview Asset Management.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)